0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
In This Issue of Archives of Internal Medicine |

In This Issue of Archives of Internal Medicine FREE

Arch Intern Med. 2008;168(18):1944. doi:10.1001/archinte.168.18.1944.
Text Size: A A A
Published online

SMOKING CESSATION INTERVENTIONS FOR HOSPITALIZED SMOKERS

Providing smoking cessation advice, counseling, or medication is a quality-of-care measure on which US hospitals are judged. To assess the effectiveness of smoking cessation interventions initiated during a hospital stay, Rigotti et al conducted a meta-analysis of 33 trials. They found that smoking counseling that began in the hospital increased the odds of smoking cessation by 65% (pooled odds ratio, 1.65; 95% confidence interval, 1.44-1.90) at 6 to 12 months after discharge, but only if supportive counseling contact continued for more than 1 month after discharge. Adding nicotine replacement therapy produced a trend toward better efficacy than counseling alone (odds ratio, 1.47; 95% confidence interval, 0.92-2.35).

See Article

ISONIAZID-MONORESISTANT TUBERCULOSIS IN THE UNITED STATES, 1993 TO 2003

This study uses US tuberculosis (TB) surveillance data to describe demographic, risk factor, and treatment outcome information for persons with isoniazid-monoresistant TB compared with persons with TB susceptible to all first-line anti-TB drugs. The number of isoniazid-monoresistant TB cases increased from 303 (4.1%) in 1993 to 351 (4.3%) in 2005. In our multivariate analysis of all TB cases reported from 1993 to 2003, patients with isoniazid-monoresistant TB were significantly more likely to be US-born Asian (adjusted odds ratio [aOR], 1.9; confidence interval [CI], 1.4-2.6), US-born Hispanic (aOR, 1.3; 95% CI, 1.1-1.5), foreign-born Asian (aOR, 1.8; 95% CI, 1.4-2.1), or foreign-born black (aOR, 1.4; 95% CI, 1.1-1.7). Isoniazid monoresistance was also associated with history of TB (aOR, 1.5; 95% CI, 1.3-1.7), failure to complete therapy within 1 year (aOR, 1.7; 95% CI, 1.5-1.8), and correctional facility residence (aOR, 1.5; 95% CI, 1.2-1.7).

See Article

A RANDOMIZED TRIAL OF A PAY-FOR-PERFORMANCE PROGRAM TARGETING CLINICIAN REFERRAL TO A STATE TOBACCO QUITLINE

Tobacco quitlines offer clinicians a means to connect their patients to evidence-based cessation treatments. This randomized study examined the effect of a pay-for-performance program on clinician referral to a state tobacco quitline. Usual care clinics (n = 25) received fax referral materials. Pay-for-performance clinics (n = 24) were offered $5000 for making 50 quitline referrals and also received monthly updates on their referral numbers. Intervention clinics referred 11.4% of smokers (n = 1483) seen during the intervention period compared with 4.2% of smokers (n = 441) in usual care clinics (P < .001). Rates of referral were similar in intervention vs usual care clinics with a history of being very engaged with quality improvement but were higher in clinics with a history of less engagement. Of all referrals, 27% resulted in quitline enrollment, corresponding to a marginal cost per additional enrollee of $300. A pay-for-performance program increases referral to quitline services, particularly among clinics with a history of less engagement with quality improvement activities.

See Article

PROCALCITONIN-GUIDED ANTIBIOTIC USE VS A STANDARD APPROACH FOR ACUTE RESPIRATORY TRACT INFECTIONS IN PRIMARY CARE

In the face of increasing bacterial resistance, a more judicious use of antibiotics in primary care is paramount. Briel et al assessed the biomarker procalcitonin in a randomized noninferiority trial to guide antibiotic use for acute respiratory tract infections in primary care. Fifty-three primary care physicians recruited 458 patients in Switzerland, each patient with an acute respiratory tract infection and in need of antibiotics. They found that procalcitonin-guided therapy was not inferior to standard therapy with respect to the number of days during which a patient's activities were restricted by a respiratory tract infection. The overall antibiotic prescription rate, however, was 72% lower for procalcitonin-guided therapy. There was no apparent difference in the proportion of patients reporting any symptoms of ongoing or relapsing infection at 28 days in the 2 groups.

See Article

THE EFFECT OF SMOKING IN MIDLIFE ON HEALTH-RELATED QUALITY OF LIFE IN OLD AGE

Strandberg et al used the longitudinal data of the Helsinki Businessmen Study, a socioeconomically similar cohort of 1674 initially healthy men, and a validated questionnaire to investigate the associations between midlife smoking and health-related quality of life in old age, 26 years later. Although many had died and more than 2 of 3 subjects had stopped smoking during the follow-up period, midlife smokers attained lower scores in all health-related quality-of-life scales compared with never smokers. An especially large negative effect was seen in heavy smokers (>20 cigarettes daily), who lost approximately 10 years of their life expectancy. Those who survived experienced a significant decline in their quality of life; the impairment of the physical functioning score of smokers was equal to a 10-year age difference in the general population. These results add a new dimension to the negative effects of smoking and should, at the individual level, encourage smokers to quit.

See Article

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.